APPENDIX II
TREATMENT OF WHIPLASH ASSOCIATED DISORDERS
SUMMARY OF ACCEPTED RANDOMIZED CONTROLLED TRIALS
Reference Quebec
ClassificationTime Since
MVC at EntryTreatments (n) Analyzed Outcome
TimeOutcome
MeasureOutcome
ResultsMcKinney60 1, 2 (3?) Excluded cervical fracture, dislo-cation, previous degenerative disease, previous whiplash.
< 72 hrs. after MVC
a. prescribed rest 10-14 days, analgesics, soft collar; advice to activate after 2 weeks. b. Physical therapy 3/wk x 6 wks: Maitland mobilization in combination with individually determined modalities, includ-ing heat/cold applications, traction, diathermy, hydro-therapy, analgesics and soft collar PRN. Advice on home exercise, posture, minimize reliance on soft collars.
c. Program of home exercises; instruction (verbal and written) re: relaxation methods, posture; advice to minimize reliance on analgesics and soft collar.
(33) (71)
(66)
1 mo 2 mos
Pain: VAS-10 (median)
ROM: lateral
flexion
(mean degrees)
Median Pain Score 0 1 mo 2 mo
a. 5.60 4.97 3.00
b. 5.32 3.28* 1.94*
c. 5.3 3.37* 1.82*
Mean (sd) ROM
0 1 mo 2 mo
a. 44(15) 42(19) 55(15)
b. 46(19) 53(20)* 64(13)*
c. 47(21) 54(20)* 64(13)*
*Group b, c vs. a: p<.01
McKinney61 " " a. " b. "
c. "
(26) (54)
(48)
2 yrs Self-reported symptoms Number (%) Asymptomatic a. 14 (54)
b. 30 (56)
c. 37 (73)*
*c vs. a, b: p=.02
APPENDIX II
TREATMENT OF WHIPLASH ASSOCIATED DISORDERS
SUMMARY OF ACCEPTED RANDOMIZED CONTROLLED TRIALS
Reference Quebec
ClassificationTime Since
MVC at EntryTreatments (n) Analyzed Outcome
TimeOutcome
MeasureOutcome
ResultsMealy62 1, 2, (3?) excluded cervical fractures
"acute" a. ice first 24 hrs, analgesics PRN, Maitland mobilization, heat, daily cervical exercises. b. analgesics PRN, soft collar, prescribed rest 2 wks, gradual activation afterward.
(31) (30)
4 wks 8 wks
Pain: VAS-10 ROM: total mobility score
Pain Mean (sd) 0 4 wks 8 wks
a. 5.7(2.4) 2.9(3.2)* 1.7(2.4)*
b. 6.4(2.3) 5.1(2.6)* 3.9(3.2)*
ROM Score Mean(sd)
0 4 wks 8 wks
a 19.9(9.7) 29.0(11.8)34.1(8.4)*
b.25(11.9)) 27.6(11.5)29.6(8.8)*
*Group a vs b: p<.05
Brodin8,9 **Not applicable. Neck pain without signs of nerve root compression; with reduced ROM
Symptoms dura-tion 0-5+ years (mechanism of in-jury not reported) a. analgesia 3 wks, wait for treatment b. analgesic 3 wks; "mock" therapy 3/wk x 3 wks: super-ficial massage, slight traction, electrical stimulation; 3 hrs education
c. as b. above, plus Stoddard manual mobilization 3/wk x 3 wks
(23) (17)
(23)
3 wks 4 wks
ROM increase >30E Pain: VAS-10
Pain n(%) Slight/
None Moderate Increased
a. *5(22) 13(56) 5(22)
b. *2(12) 13(77) 2(12)
c. *11(48) 11(48) 1( 4)
3 wks ROM increase >30E
n(%)
a. 7(30)
b. 6(35)
c. 15(65%)**
* group c vs. a, b: p<.05
APPENDIX II
TREATMENT OF WHIPLASH ASSOCIATED DISORDERS
SUMMARY OF ACCEPTED RANDOMIZED CONTROLLED TRIALS
Reference Quebec
ClassificationTime Since
MVC at EntryTreatments (n) Analyzed Outcome
TimeOutcome
MeasureOutcome
ResultsCassidy13 Neck pain excludes neurologic signs. 31% MVC Pain duration <1 wk. to 6 mos.
a. single manipulation b. single manual mobilization (Bourdillon & Day)
(52) (48)
Base-line, Immed.post-treat-ment Pain NRS-101
ROM: flexion/ extension rotation, lateral flexion
Pain Mean (sd) a b
Baseline 38(26) 31(20)
Immed 20(21) 21(21)
Change 17(20) 11(15)
ROM
No differences between groups
Zylbergold122 Not applicable. Neck pain, mixed diagnoses. 13% neck strain. Age <70 yrs. Included radicular pain. Excluded prior neck surgery, RA, osteoporosis. Not reported. a. Static traction, neck care, moist heat, program of neck exercises. 2/wk x 6 wks. b. Intermittent traction, neck care, moist heat, program of neck exercises 2 wk x 6 wks.
c. Manual traction, neck care, moist heat, program of neck exercises 2/wk x 6 wks.
d. Neck care, moist heat, pro-gram of neck exercises (con-trol) 2/wk x 6 wks.
(25) (25)
(25)
(25)
Base-line (Pre) Dis-charge (Post)
Pain: McGill present intensity. ROM (degrees), F. Flexion, Ext, R. Rot., L. Rot., R. Flex., L. Flex
Pain Change Mean (sd) All Traction Control
-1.27(0.97) -0.88(1.17)
ROM Change Mean (sd)
All
Traction Control
F.Flex 17.8(15.9)10.6(16.1)*
Ext. 9.6(11.2) 13.6(13.2)
R. Rot. 18.4(17.2)10.0(18.7)*
L. Rot. 10.3(17.1) 16.9(16.7)
R. Flex. 12.2( 9.7) 10.2(10.8)
L. Flex. 11.0(12.5) 11.8(11.6)
*p<0.05
APPENDIX II
TREATMENT OF WHIPLASH ASSOCIATED DISORDERS
SUMMARY OF ACCEPTED RANDOMIZED CONTROLLED TRIALS
Reference Quebec
ClassificationTime Since
MVC at EntryTreatments (n) Analyzed Outcome
TimeOutcome
MeasureOutcome
ResultsFoley-Nolan27 1, 2 (3?) Excluded impaired reflexes indicative of cervical root lesion.f
<72 hrs. a. 8hr/day x 12 wks Soft collar with active PEMT; NSAIDS PRN; advice to mobilize neck hourly; addition of physiotherapy at 4 wks at patient request. b. 8hr/day x 12 wks Soft collars with Sham PEMT (control); other treatment as in a.
(20) (20)
Base-line 2 wks
4 wks
12 wks
Pain: VAS-10 ROM: Total mobil-ity score (0-6 range). Analgesic intake.
Pain (median) Base
line 2 wk 4 wk 12 wk
a. 6.8 3.8* 2.5* 1.5
b. 6.3 6.0 5.0 2.2
ROM (median)
Base
line 2 wk 4 wk 12 wk
a. 2.8* 3.0 4.0 4.5*
b. 3.7 3.5 3.3 4.0
Daily number analgesics
(median)
Base
line 2 wk 4 wk 12 wk
a. 5.0 3.5* 2.5* 0*
b. 6.0 6.0 5.0 1.5
*Group a vs. b: p<.05
APPENDIX II
TREATMENT OF WHIPLASH ASSOCIATED DISORDERS
SUMMARY OF ACCEPTED RANDOMIZED CONTROLLED TRIALS
Reference Quebec
ClassificationTime Since
MVC at EntryTreatments (n) Analyzed Outcome
TimeOutcome
MeasureOutcome
ResultsByrn11 1,2 (3?) 4-6 years a. subcutaneous sterile water trigger point injections x 2 months as required b. subcutaneous sterile saline trigger point injections x 2 months as required(Control)
(20) (20)
Base-line Immed. 1 mo.
3 mos.
8 mos.
Pain: VAS-10 ROM: Sum score
Pain (mean) a b
Baseline 4.0 3.6
Change----------------------
Immed 0.8* 2.0*
1 mo. 2.1 3.4
3 mos. 2.3* 4.0*
8 mos. 2.4* 4.7*
ROM (mean)
a b
Baseline 288 291
Change----------------------
Immed +54* +23
1 mo. +36* +5
3 mos. +39* +6
8 mos. +20* -11
*Group a vs. b: p<.05
Barnsley3 painful cervical zygapophysial
joint pain after
whiplash injury
> 3 months a. single intraarticular injection 1.0 ml bupivacaine (0.5 percent) (Control) b. single intraarticular injection 1.0 ml betamethasone (5.7 mg) (Corticosteroids)
Both groups: usual analgesics and physiotherapy
(20) (21)
Base- line
1, 4, 6, 8, 16, 20 weeks
base-line 2, 12 weeks
Primary outcome: estimate time to return to 50% of baseline pain Other outcome: VAS
McGill
Median time to return to 50% of baseline pain a (control)3.5 days
b (corticosteroid) 3 days*
*N.S., p=.42
APPENDIX II
TREATMENT OF WHIPLASH ASSOCIATED DISORDERS
SUMMARY OF ACCEPTED RANDOMIZED CONTROLLED TRIALS
Reference Quebec
ClassificationTime Since
MVC at EntryTreatments (n) Analyzed Outcome
TimeOutcome
MeasureOutcome
ResultsHong42 Not applicable. Chronic neck pain. Mechanism not reported. Pain duration >1 year
a. Magnetic necklace 24 hr/day x 3 wks. b. Non-magnetic necklace 24 hr/day x 3 wks (control)
(27) (25)
Base-line 3 wks
Pain: intensity (0-4) frequency (0-4)
Pain Intensity Mean (sd) Baseline 3 wks
a. 3.1(0.5) 2.7(0.7)
b. 2.8(0.6) 2.6(0.6)
Pain Frequency Mean (sd)
Baseline 3 wks
a. 2.9(0.6) 2.5(0.6)
b. 2.8(0.6) 2.5(0.7)